🔎 Trials Near Me

Beranda › Gangguan Depresi Mayor › Massachusetts › Boston

Uji klinis Gangguan Depresi Mayor di Boston, MA

31 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical Boston, Boston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07775300

A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical Boston, Boston
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07573176

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Menerima pesertaFase 3
  • Boston Childrens Hospital, Boston
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07227454

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical Boston, Boston
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06793397

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Menerima pesertaFase 3
  • Vanda Investigational Site, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06830044

Accelerated TMS for Perinatal Depression

Menerima peserta
  • Brigham and Women's Hospital, Boston
Usia 18 hingga 55 · Wanita · Diperbarui 18 Sep 2026 · NCT06968390

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Menerima pesertaFase 2
  • Seaport Investigator Site, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

Menerima pesertaFase 3
  • Adams Clinical Boston, Boston
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07076407

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Menerima pesertaFase 2
  • Draig Clinical Site, Boston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Menerima peserta
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06423430

Home-Based tDCS Treatment Of Major Depressive Disorder

Menerima peserta
  • Curavit Clinical Research (virtual study site), Boston
Usia 22 hingga 70 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06976697

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

Menerima pesertaFase 3
  • Athinoula A. Martinos Center for Biomedical Imaging, Charlestown · 1 mi jauhnya
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06247839

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Menerima pesertaFase 3
  • Adams Clinical Boston, Boston
  • Adams Clinical Watertown, Boston
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07592689

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Adams Clinical Boston, Boston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Menerima pesertaFase 3
  • Boston Clinical Trials Llc, Boston
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06966401

Triage Survey for Psychiatry Research Eligibility

Menerima pesertaStudi observasional
  • Adams Clinical, Boston, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT05800925

Mechanisms Of Orbitofrontal Stimulation in Depression

Menerima peserta
  • Beth Israel Deaconess Medical Center, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT07230990

Mindfulness-Based fMRI Neurofeedback for Depression

Menerima peserta
  • Northeastern University, Boston
Usia 13 hingga 18 · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT05617495

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

Menerima pesertaFase 3Sukarelawan sehat diterima
  • Lindus Health (Virtual Study Site), Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT07280065

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Menerima pesertaStudi observasional
  • Beth Israel Deaconess Medical Center, Boston
Usia 18 hingga 40 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06740383

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

Menerima peserta
  • Harvard Medical School, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05573074

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Menerima pesertaFase 2
  • Autobahn Site #137, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06633016

Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression

Menerima pesertaFase 4
  • Massachusetts General Hospital, Boston
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 12 Des 2025 · NCT05450432

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06786624

Targeting Specific Brain Networks to Treat Specific Symptoms in Depression

Menerima pesertaSukarelawan sehat diterima
  • Massachusetts General Hospital, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Sep 2025 · NCT05523817

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Menerima pesertaFase 2
  • Massachusetts General Hospital, Boston
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 12 Sep 2025 · NCT05570812

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Menerima pesertaSukarelawan sehat diterima
  • Massachusetts General Hospital, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 10 Sep 2025 · NCT04296604

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Menerima pesertaFase 2
  • Massachusetts General Hospital, Boston
Usia 25 hingga 50 · Semua jenis kelamin · Diperbarui 7 Mei 2025 · NCT06136546

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Menerima pesertaFase 4
  • Clinical Research Site, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jan 2025 · NCT06223880

Peripheral Neuroimmune Mechanisms of Hyperthermia

Menerima peserta
  • Massachusetts General Hospital Depression Clinical & Research Program, Boston
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 10 Mar 2023 · NCT05366270

Uji klinis Gangguan Depresi Mayor di kota lain

Studi lain di Boston

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.